Alembic Pharma hits record high on USFDA nod for anti psychotic drug

Alembic Pharmaceuticals jumped 7.65% to Rs 1,168.75 after the drug maker received final approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA), Fluphenazine Hydrochloride tablets.